|
Symbol
|
RMBQ5V | KZEHDU | KZJVDU | RMBAIV | RMA09V | RMBX5V | ACMVSQ | ADAATQ | RMAY9V | RMBACV | ADXETQ | DAGBKB | LAUJDU | 1129BC | AEEBTQ | AEACTQ | ADAGSQ | AENOTQ | BCPBIL | AEHHTQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Callable Multi Defender Vonti | Autocallable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible |
|
Sous-jacent
|
Eli Lilly & Co. / Novo Nordisk AS (B) / Roche PS / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Novo Nordisk AS (B) / Philips Electronics N.V. / Roche PS / Siemens Healthineers | Novo Nordisk AS (B) / SAP SE | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Lonza Group N / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Novartis AG / Novo Nordisk AS (B) / Roche PS / Sanofi S.A. | Eli Lilly & Co. / Novartis AG / Novo Nordisk AS (B) / Roche PS | Bayer AG / Novo Nordisk AS (B) / Sanofi S.A. | Eli Lilly & Co. / Novartis AG / Novo Nordisk AS (B) / Roche PS | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Bayer AG / Eli Lilly & Co. / Novo Nordisk AS (B) | Bayer AG / Novo Nordisk AS (B) / Sanofi S.A. | Eli Lilly & Co. / Novo Nordisk AS (B) | Novo Nordisk AS (B) / Stellantis N.V. | Bayer AG / Eli Lilly & Co. / Novo Nordisk AS (B) |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
17.11.2026 | 20.11.2026 | 30.12.2026 | 30.12.2026 | 12.05.2027 | 16.11.2026 | 23.11.2026 | 27.11.2026 | 14.01.2027 | 25.01.2027 | 12.02.2027 | 12.02.2027 | 01.03.2027 | 05.03.2027 | 08.12.2026 | 16.03.2027 | 22.12.2026 | 07.04.2027 | 08.10.2030 | 14.01.2027 |
| Demande | 37,500 | 35,350 | 33,500 | 46,100 | 64,40 | 63,30 | 66,17 | 63,03 | 61,00 | 97,30 | 102,41 | 103,93 | 100,60 | 96,63 | 100,80 | 99,35 | 102,55 | 92,23 | 70,94 | 97,02 |
| Offre | - | 36,350 | - | - | - | 65,00 | - | - | - | 98,50 | 103,28 | 104,82 | 101,60 | 97,40 | - | 100,20 | 103,43 | 93,08 | 71,65 | - |